Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.
- 1 February 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (3), 859-863
- https://doi.org/10.1073/pnas.82.3.859
Abstract
Proteins binding the 3rd component of complement (C3) were isolated by affinity chromatography from surface-labeled solubilized membranes of human peripheral blood cells and cell lines. The isolated molecules were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and autoradiographs of these gels indicated that C3-binding proteins could be divided into 3 groups based on MW: (i) gp200, an .apprxeq. 200,000 MW molecule previously identified as the C3b/C4b receptor or CR1; (ii) gp140, and .apprxeq. 140,000 MW molecule previously identified as the C3d receptor or CR2; and (iii) gp45-70, a heretofore unrecognized group of 45,000-70,000 MW C3-binding molecules. The cell distribution, MW, antigenic cross-reactivity, and specificity of gp45-70 were examined. Erythrocytes have no detectable gp45-70, but all leukocyte populations examined possess this group of molecules. On neutrophils and mononuclear phagocytes, CR1 is the predominant C3-binding glycoprotein, but gp45-70 is present on both cell populations and on macrophage and neutrophil cell lines. B plus null cells, chronic lymphocytic leukemia cells, and an Epstein-Barr virus-transformed B-cell line possess CR1, CR2 and gp45-70. On T cells and T-cell lines gp45-70 is the predominant or, in some cases, the only C3-binding protein isolated. gp45-70 is structurally characterized as a broad band or doublet with a mean MW that is slightly different for each cell population. gp45-70 binds iC3, C3b, and C4b, but not C3d, indicating that the binding region is probably within the C3c portion of C3b. A polyclonal antibody to CR1 and monoclonal antibodies to CR1 and CR2 do not immunoprecipitate gp45-70. While gp45-70 has not been previously characterized on human cells, a C3b-binding glycoprotein of similar MW is present on rabbit alveolar macrophages. Evidently, gp45-70 is an additional group of membrane proteins present on human leukocytes that possess ligand-binding activity for C3b.This publication has 29 references indexed in Scilit:
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.The Journal of Experimental Medicine, 1984
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.The Journal of Experimental Medicine, 1983
- Genetic regulation of a structural polymorphism of human C3b receptor.Journal of Clinical Investigation, 1983
- Mode of Inheritance of Decreased C3b Receptors on Erythrocytes of Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1982
- Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.The Journal of Experimental Medicine, 1982
- Isolation and characterization of a C3b receptor‐like molecule from membranes of a human B lymphoblastoid cell line (Raji)FEBS Letters, 1981
- DEFECTIVE IMMUNE-ADHERENCE (C3b) RECEPTOR ON ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1981
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970